Sign inGet started

JOHNSON CHAD ALLEN

Insider CIK 1734108 · (NLNK) Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-134,227— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-132,777— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-133,328— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-133,345— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-132,910— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-133,431— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer deriv2024-12-122024-12-135,684— $00SEC↗
(LUMO) LUMOS PHARMA, INC. D To issuer2024-12-122024-12-131,076— $00SEC↗
(LUMO) LUMOS PHARMA, INC. A Award deriv2024-06-052024-06-073,328— $03,328SEC↗
(LUMO) LUMOS PHARMA, INC. A Award deriv2023-05-102023-05-123,345— $03,345SEC↗
(LUMO) LUMOS PHARMA, INC. A Award deriv2022-05-052022-05-093,431— $03,431SEC↗
(LUMO) LUMOS PHARMA, INC. A Award deriv2021-05-202021-05-242,910— $02,910SEC↗
(LUMO) LUMOS PHARMA, INC. A Award2021-05-202021-05-24367— $01,076SEC↗
(LUMO) LUMOS PHARMA, INC. A Award deriv2020-04-032020-04-075,684— $05,684SEC↗
(LUMO) LUMOS PHARMA, INC. A Award2020-04-032020-04-07709— $0709SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2019-07-312019-08-0213,889— $013,889SEC↗
(NLNK) NEWLINK GENETICS CORP D To issuer deriv2019-07-312019-08-0227,777— $00SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2019-07-312019-08-0213,424— $013,424SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2019-07-312019-08-0210,739— $010,739SEC↗
(NLNK) NEWLINK GENETICS CORP D To issuer deriv2019-07-312019-08-0248,324— $00SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2019-05-102019-05-1425,000— $025,000SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2018-05-232018-05-2527,777— $027,777SEC↗